To further explore the effect of 23-HBA inhibition of IL-10 release from M2 macrophages on chemotherapy resistance in colorectal cancer, we conducted an analysis of STAT3 and Bcl-2, both of which serve as key mediators within the IL-10 signaling pathway. Here, STAT3 is linked to colorectal cancer.